Indoor and outdoor artificial light at night (ALAN) and cancer risk: A systematic review and meta-analysis of multiple cancer sites and with a critical appraisal of exposure assessment.

Artificial light-at-night Cancer Circadian disruption Meta-analysis Systematic review

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Oct 2024
Historique:
received: 03 07 2024
revised: 26 09 2024
accepted: 17 10 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

Exposure to artificial light-at-night (ALAN) has been linked to cancer risk. Few meta-analyses on this topic have reviewed only breast cancer. This study aimed to systematically review and meta-analyze existing studies on ALAN exposure and cancer incidence, thoroughly evaluating exposure assessment quality. We considered observational studies (cohort, case-control, cross-sectional) on ALAN exposure (indoor and outdoor) and cancer incidence, measured by relative risk, hazard ratio, and odds ratio. We searched six databases, two registries, and Google Scholar from inception until April 17, 2024. Quality of studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools. Random-effects meta-analysis was used to estimate relative risks (RR) and 95 % confidence intervals (CI) for ALAN exposures. We identified 9835 studies and included 28 for qualitative synthesis with 2,508,807 individuals (15 cohort, 13 case-control). Out of the included studies, 20 studies on breast cancer (731,493 individuals) and 2 studies on prostate cancer (53,254 individuals) were used for quantitative synthesis. Higher levels of outdoor ALAN were associated with breast cancer risk (meta-estimate = 1.12, 95 % CI 1.03-1.23 (I

Identifiants

pubmed: 39437923
pii: S0048-9697(24)07216-4
doi: 10.1016/j.scitotenv.2024.177059
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

177059

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Auteurs

Anna Palomar-Cros (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBERESP, Madrid, Spain; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.

Andy Deprato (A)

Alberta Respiratory Centre, Division of Pulmonary Medicine, University of Alberta, Edmonton, Alberta, Canada; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

Kyriaki Papantoniou (K)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.

Kurt Straif (K)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Boston College, Chestnut Hill, MA, United States.

Paige Lacy (P)

Alberta Respiratory Centre, Division of Pulmonary Medicine, University of Alberta, Edmonton, Alberta, Canada.

Robert Maidstone (R)

Division of Immunology, Immunity to Infection, and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.

Ana Adan (A)

Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

Prasun Haldar (P)

Department of Medical Laboratory Technology, Supreme Institute of Management and Technology, Mankundu, India.

Saibal Moitra (S)

Department of Allergy and Immunology, Apollo Gleneagles Hospital, Kolkata, India.

José Francisco Navarro (JF)

Department of Psychobiology and Methodology of Behavioural Sciences, University of Málaga, Málaga, Spain.

Hannah Durrington (H)

Division of Immunology, Immunity to Infection, and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.

Subhabrata Moitra (S)

Alberta Respiratory Centre, Division of Pulmonary Medicine, University of Alberta, Edmonton, Alberta, Canada; Canadian VIGOUR Centre, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Bagchi School of Public Health, Ahmedabad University, Ahmedabad, Gujarat, India.

Manolis Kogevinas (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBERESP, Madrid, Spain; Hospital del Mar Research Institute, Barcelona, Spain.

Barbara N Harding (BN)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBERESP, Madrid, Spain. Electronic address: barbara.harding@isglobal.org.

Classifications MeSH